155 related articles for article (PubMed ID: 37441745)
1. Should Neoadjuvant Treatment Be Adopted More Widely for Patients With Extremity Soft Tissue Sarcoma in Low-Income Countries?
Mangla A
JCO Glob Oncol; 2023 Jul; 9():e2300110. PubMed ID: 37441745
[No Abstract] [Full Text] [Related]
2. Extremity soft tissue sarcoma: evidence-based multidisciplinary management.
Scoggins CR; Pollock RE
J Surg Oncol; 2005 Apr; 90(1):10-3. PubMed ID: 15786434
[No Abstract] [Full Text] [Related]
3. Prognostic significance of treatment-induced pathologic necrosis in extremity and truncal soft tissue sarcoma after neoadjuvant chemoradiotherapy.
Mullen JT; Hornicek FJ; Harmon DC; Raskin KA; Chen YL; Szymonifka J; Yeap BY; Choy E; DeLaney TF; Nielsen GP
Cancer; 2014 Dec; 120(23):3676-82. PubMed ID: 25081640
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemoradiation therapy for soft tissue sarcomas of the extremities.
Aguiar Junior S; Ferreira Fde O; Rossi BM; Santos EM; Salvajoli JV; Lopes A
Clinics (Sao Paulo); 2009; 64(11):1059-64. PubMed ID: 19936179
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemoradiation (modified Eilber protocol) versus adjuvant radiotherapy in the treatment of extremity soft tissue sarcoma.
Lehane C; Ho F; Thompson SR; Links D; Lewis C; Smee R; Parasyn A; Friedlander M; Williams J; Crowe P
J Med Imaging Radiat Oncol; 2016 Aug; 60(4):539-44. PubMed ID: 26936092
[TBL] [Abstract][Full Text] [Related]
6. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.
Gronchi A; Ferrari S; Quagliuolo V; Broto JM; Pousa AL; Grignani G; Basso U; Blay JY; Tendero O; Beveridge RD; Ferraresi V; Lugowska I; Merlo DF; Fontana V; Marchesi E; Donati DM; Palassini E; Palmerini E; De Sanctis R; Morosi C; Stacchiotti S; Bagué S; Coindre JM; Dei Tos AP; Picci P; Bruzzi P; Casali PG
Lancet Oncol; 2017 Jun; 18(6):812-822. PubMed ID: 28499583
[TBL] [Abstract][Full Text] [Related]
7. Histological response assessment following neoadjuvant isolated limb perfusion in patients with primary, localised, high-grade soft tissue sarcoma.
Andreou D; Werner M; Pink D; Traub F; Schuler MK; Gosheger G; Jobke B; Reichardt P; Tunn PU
Int J Hyperthermia; 2016; 32(2):159-64. PubMed ID: 26670477
[TBL] [Abstract][Full Text] [Related]
8. Surgical Resection Margin Classifications for High-grade Pleomorphic Soft Tissue Sarcomas of the Extremity or Trunk After Neoadjuvant Cytotoxic Therapy.
Cates VM; Cates JMM
Am J Surg Pathol; 2019 Jun; 43(6):844-850. PubMed ID: 30932925
[TBL] [Abstract][Full Text] [Related]
9. Does Vacuum-assisted Closure Reduce the Risk of Wound Complications in Patients With Lower Extremity Sarcomas Treated With Preoperative Radiation?
Bedi M; King DM; DeVries J; Hackbarth DA; Neilson JC
Clin Orthop Relat Res; 2019 Apr; 477(4):768-774. PubMed ID: 30811365
[TBL] [Abstract][Full Text] [Related]
10. Is a Nomogram Able to Predict Postoperative Wound Complications in Localized Soft-tissue Sarcomas of the Extremity?
Bedi M; Ethun CG; Charlson J; Tran TB; Poultsides G; Grignol V; Howard JH; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Cullinan D; Fields RC; Cardona K; King DM
Clin Orthop Relat Res; 2020 Mar; 478(3):550-559. PubMed ID: 32168066
[TBL] [Abstract][Full Text] [Related]
11. [Multimodal management in soft tissue sarcoma of the trunk and extremities].
Ghadimi MP; Rehders A; Knoefel WT
Chirurg; 2014 May; 85(5):378-82. PubMed ID: 24733613
[TBL] [Abstract][Full Text] [Related]
12. Reconstruction of sarcoma defects following pre-operative radiation: free tissue transfer is safe and reliable.
Townley WA; Mah E; O'Neill AC; Wunder JS; Ferguson PC; Zhong T; Hofer SO
J Plast Reconstr Aesthet Surg; 2013 Nov; 66(11):1575-9. PubMed ID: 23831122
[TBL] [Abstract][Full Text] [Related]
13. National evaluation of patterns and predictors of underuse of multimodal therapy for high-risk extremity soft tissue sarcoma.
Nigam A; Aminpour N; Zeymo A; Desale S; Villano AM; Unger KR; Aboulafia AJ; Al-Refaie WB
Surgery; 2022 May; 171(5):1348-1357. PubMed ID: 35123797
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant therapy for soft tissue sarcomas: does it make a difference?
Scoggins CR
Cancer; 2008 Jun; 112(11):2338-40. PubMed ID: 18338757
[No Abstract] [Full Text] [Related]
15. [Multi-disciplinary approach in management of extremity soft tissue sarcoma].
Niu XH
Zhonghua Wai Ke Za Zhi; 2011 Nov; 49(11):961-3. PubMed ID: 22333412
[No Abstract] [Full Text] [Related]
16. The evolution of adjuvant/neoadjuvant trials for resectable localized sarcoma.
Gervais MK; Callegaro D; Gronchi A
J Surg Oncol; 2022 Jan; 125(1):17-27. PubMed ID: 34897708
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant Therapy for Soft-Tissue Sarcomas-One Size Does Not Fit All.
Singh AS; Eilber FC
Oncology (Williston Park); 2016 Jan; 30(1):107-8. PubMed ID: 26791853
[No Abstract] [Full Text] [Related]
18. Patient's quality of life after surgery and radiotherapy for extremity soft tissue sarcoma - a retrospective single-center study over ten years.
Götzl R; Sterzinger S; Semrau S; Vassos N; Hohenberger W; Grützmann R; Agaimy A; Arkudas A; Horch RE; Beier JP
Health Qual Life Outcomes; 2019 Nov; 17(1):170. PubMed ID: 31703704
[TBL] [Abstract][Full Text] [Related]
19. Trimodality Treatment of Extremity Soft Tissue Sarcoma: Where Do We Go Now?
Oberoi S; Choy E; Chen YL; Scharschmidt T; Weiss AR
Curr Treat Options Oncol; 2023 Apr; 24(4):300-326. PubMed ID: 36877374
[TBL] [Abstract][Full Text] [Related]
20. Combined modality treatment of extremity soft tissue sarcomas.
Pisters PW
Ann Surg Oncol; 1998; 5(5):464-72. PubMed ID: 9718178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
